UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q /A1

(Mark One)

√QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:  June 30, 2008

oTRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

For the transition period from to

Commission file number:0-12968

InMedica Development Corporation

(Exact name of small business issuer as specified in its charter)

UTAH	87-0397815
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

825 North 300 West, Suite N132

Salt Lake City, Utah 84103

(Address of principal executive offices)

(801) 521-9300

(Issuer’s telephone number)

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes √No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	Accelerated filer
Non-accelerated filer	√ Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes oNo √

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date:18,629,493 shares of $.001 par value common stock as of August 31 , 2008.

The Company hereby amends and restates in its entirety, the Consolidated Balance Sheet of the Company filed with Form 10Q for the period ended June 30, 2008 to include comparative data for December 31, 2007, as shown below.

INMEDICA DEVELOPMENT CORPORATION AND SUBSIDIARY

CONSOLIDATED BALANCE SHEET

ASSETS
	As of		As of
	June 30,		December 31,
	2008		2007
	(Unaudited)		(audited)
CURRENT ASSETS:
Cash & cash equivalents	$	5,075	$	2,706
Prepaid expenses and other		200		200
Total current assets		5,275		2,906
EQUIPMENT AND FURNITURE, at cost,
less accumulated depreciation of
$255,039 and $254,856 respectively		183		365
Total assets	$	5,458	$	3,271

See notes to consolidated financial statements

INMEDICA DEVELOPMENT CORPORATION AND SUBSIDIARY

CONSOLIDATED BALANCE SHEET (Continued)

LIABILITIES AND STOCKHOLDERS' EQUITY
	As of			As of
	June 30,			December 31,
	2008			2007
	(Unaudited)			(Unaudited)
CURRENT LIABILITIES:
Related party consulting fees payable	$	90,000		$	78,000
Accounts payable		35,975			5,503
Accrued payroll		24,000			-
Accrued interest		25,009			16,495
Related party royalty payable		93,333			73,333
Preferred stock dividend payable		52,960			49,177
Current portion of long term debt		140,000			60,617
Total current liabilities		461,277			283,125
LONG TERM LIABILITIES
Long term convertible promissory note		87,633			140,000
TOTAL LIABILITIES		548,910			423,125
MINORITY INTEREST		(243,645	)		(191,668	)
STOCKHOLDERS' EQUITY:
Preferred stock, 10,000,000
shares authorized;  Series A
preferred stock, cumulative and
convertible, $4.50 par value,
1,000,000 shares designated,
21,016 shares issued and
Outstanding		94,573			94,573
Common stock, $.001 par value;
40,000,000 shares authorized,
18,629,493 issued and outstanding		18,629			18,629
Additional paid-in capital		8,426,839			8,426,839
Accumulated deficit		(8,839,848	)		(8,768,227	)
Total stockholders equity		(299,807	)		(228,186	)
Total liabilities and stockholders' equity	$	5,458		$	3,271

See notes to consolidated financial statements

Item 6.   Exhibits:

(31.1)                      Sarbanes-Oxley Section 302 Certification – Ralph Henson

(31.2)                      Sarbanes- Oxley Section 302 Certification- Richard Bruggeman

(32.1)                      Sarbanes-Oxley Section 906 Certification

SIGNATURES

In accordance with the requirements of the Exchange Act, the registr­ant caused this amended report to be signed on its behalf by the undersigned, thereun­to duly authorized.

INMEDICA DEVELOPMENT CORPORATION

/s/ Ralph Henson

By  Ralph Henson, President

/s/ Richard Bruggeman

By  Richard Bruggeman, Treasurer

Date:   September 26 , 2008

EXHIBIT INDEX - INMEDICA DEVELOPMENT CORPORATION

FORM 10Q/A1 – JUNE 30, 2008

EXHIBIT NUMBER   DESCRIPTION

(31.1)                      Sarbanes-Oxley Section 302 Certification – Ralph Henson

(31.2)                      Sarbanes- Oxley Section 302 Certification- Richard Bruggeman

(32.1)                      Sarbanes-Oxley Section 906 Certification